Coughlin Christina M.

Number of records: 1

SEC Filing	Company/Stock	Trade Date	Transaction	Shares	Avg. Price	Total	% Holdings	Gain/Loss
24-Apr-20 4:13 PM View:	Rubius Therapeutics, Inc. (RUBY)	22-Apr-20	Market Purchase	19,000	$5.52	$104,814.00	100% 0 to 19.0K	160%